26514744|t|Synthesis of donepezil-based multifunctional agents for the treatment of Alzheimer's disease.
26514744|a|Amyloid beta (Abeta) and cholinesterase enzymes (AChE, BuChE) are important biological targets for the effective treatment of Alzheimer's disease. In this study, the aim was to synthesize new donepezil-like secondary amide compounds that display a potent inhibition of cholinesterases and Abeta with antioxidant and metal chelation abilities. All test compounds showed activities against both ChEs and beta1-42 inhibition. The most encouraging compound, 20, is an AChE inhibitor with high anti-aggregation activity (55.3%). Based on the results, compound 20 may be a promising structure in further research for new anti-Alzheimer's agents. 
26514744	13	22	donepezil	Chemical	MESH:D000077265
26514744	73	92	Alzheimer's disease	Disease	MESH:D000544
26514744	94	106	Amyloid beta	Gene	351
26514744	108	113	Abeta	Gene	351
26514744	119	133	cholinesterase	Gene	590
26514744	143	147	AChE	Gene	43
26514744	220	239	Alzheimer's disease	Disease	MESH:D000544
26514744	286	295	donepezil	Chemical	MESH:D000077265
26514744	301	326	secondary amide compounds	Chemical	-
26514744	383	388	Abeta	Gene	351
26514744	410	415	metal	Chemical	MESH:D008670
26514744	558	562	AChE	Gene	43
26514744	640	651	compound 20	Chemical	MESH:C028342
26514744	714	725	Alzheimer's	Disease	MESH:D000544
26514744	Negative_Correlation	MESH:C028342	MESH:D000544
26514744	Association	MESH:D000077265	MESH:D008670
26514744	Negative_Correlation	MESH:D000077265	351
26514744	Association	MESH:D000544	351
26514744	Association	MESH:D000544	590
26514744	Negative_Correlation	MESH:D000077265	MESH:D000544
26514744	Association	MESH:D008670	351
26514744	Association	MESH:D000544	43

